Articles from ARC Fertility

CUPERTINO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, has been named the winner of the 2025 MedTech Breakthrough Award for “Best Reproductive Health Technology Solution.” The award recognizes ARC’s commitment to delivering innovative, inclusive and tech-enabled fertility care that improves outcomes and expands access for all.

CUPERTINO, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility, family-forming and women’s and men’s health benefits for employers and their employees, has been named to BenefitsPRO Luminaries Class of 2024 in the category of Humanizing Benefits.

CUPERTINO, Calif. and MELBOURNE, Australia, Oct. 08, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, is proud to announce a strategic partnership with Sapyen, a global innovator in at-home male fertility testing. This collaboration provides opportunities for employers to offer their male employees and health plan members a seamless fertility testing experience from the comfort and privacy of their homes, a significant benefit as 1 in 6 couples faces difficulties in conceiving, 50% of all fertility issues are male-related and many studies show there has been a significant decline in sperm count globally over the last fifty years,

CUPERTINO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- As October marks World Menopause Awareness Month, ARC Fertility (ARC), a highly experienced national provider of innovative fertility, family-forming and women’s and men’s health benefits for employers and their employees, encourages employers to prioritize menopause and perimenopause support within their comprehensive benefit offerings. Menopause typically occurs between ages 45-55 when periods stop permanently and perimenopause is the transition leading up to it. These life stages can bring significant physical, emotional and mental challenges, impacting workplace productivity and well-being.

CUPERTINO, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, is pleased to announce its sponsorship at the Purchaser Business Group on Health (PBGH) 2024 Maternal Health and Birth Equity Summit, Wednesday, September 18, 8:00am to 4:00pm MT Denver, Colorado. This pivotal event gathers a diverse group of stakeholders, including employers, public purchasers, providers, health plans, patients and government agencies, to discuss and strategize on how to address maternal morbidity and mortality, eliminate disparities and improve birth outcomes across the United States.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, is pleased to announce the availability of its new white paper, “Unlock Company Growth with Family-Forming Benefits,” which is now available for download. This comprehensive guide provides opportunities for employers to enhance their benefits packages with high-quality, cost-effective and flexible family-forming solutions that boost employee recruitment and retention.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, proudly announces that it has been honored with a Gold Globee Award for Achievement in Health and Wellness at the 9th Annual 2024 Globee Awards for American Business. This prestigious recognition underscores ARC's commitment to delivering high-quality, comprehensive and flexible family-forming benefits to a diverse range of individuals and couples.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, was selected as a winner in the Spring 2024 Digital Health Awards® program. “FertilityNow® – The Revolutionary Reproductive Health App for Personalized Fertility Estimation for Every Journey” received a Merit Award for Mobile Digital Health Resources – Mobile Application.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, is excited to announce that it has earned the prestigious Spotlight Award in the Fertility and Maternity category at the Validation Institute’s Seventh Annual Health Value Awards. This honor from one of the most respected healthcare evaluation organizations underscores ARC’s commitment to providing high-quality, cost-effective and flexible fertility care and follows dual recognitions from the Validation Institute for both cost-savings and superior outcomes in 2024.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, proudly announces dual recognitions from the Validation Institute (VI) for both cost-savings and superior outcomes in 2024. This two-fold independent acknowledgement of its commitment to providing high-quality, cost-effective fertility care follows a 2023 VI Award for an exceptional cost savings report.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, is proud to announce the publication of "Achieving more equitable access to assisted reproduction," in the British Medical Journal (BMJ). In this study, David Adamson, MD, founder and CEO, ARC joins co-authors S.J. Dyer, M.C. Inhorn, and F. Zegers-Hochschild in advocating for more inclusive fertility treatment, emphasizing the importance of social action to address the burden of infertility.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its selection as a finalist in two categories at the recently held prestigious FemTech World Awards 2024 ceremony. The FemTech Awards, recognizing outstanding achievements in women's health technology, shortlisted ARC for the "Company of the Year," sponsored by Guidea and "Gender Inclusive Employer," sponsored by Wellbeing of Women.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its recognition by the Validation Institute with the 2023 Award for its exceptional cost savings report. The award highlights ARC Fertility's commitment to delivering value-driven solutions that optimize employer-sponsored fertility benefits and enhance member experiences.

ARC® Fertility, a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly recognizes National Infertility Awareness Week® (NIAW), an event founded by RESOLVE in 1989. The week-long observation aims to dispel myths and misinformation surrounding infertility, fostering a supportive community for those facing family-building challenges.

ARC® Fertility, a national provider of innovative family-forming benefits, is calling upon its community of patients and the wider infertility community to #LeaveYourMark during National Infertility Awareness Week (NIAW), April 21-27. Organized annually by RESOLVE: The National Infertility Association, NIAW is the largest public awareness campaign that addresses this public health issue which affects 1 in 6 people worldwide.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers, health plans, unions and their members, is pleased to announce its upcoming webinar in collaboration with the Pittsburgh Business Group on Health (PBGH). The webinar, "Empowering the Workforce: The Strategic Imperative of Reproductive Health Benefits in Modern Workplace Culture," will shed light on the critical role of fertility benefits in today's evolving healthcare landscape and their impact on employee well-being, company culture and diversity, equity and inclusion (DEI) goals.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers, health plans, unions and their members, is honored to announce its selection as one of the seven remarkable femtech innovators shortlisted for Femtech World's prestigious Company of the Year award. Sponsored by Guidea, a renowned product design agency specializing in digital health design, this award recognizes organizations at the forefront of revolutionizing women's health and wellness.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, is excited to announce the release of four compelling case studies showcasing successful partnerships with self-insured employers. These case studies exemplify ARC's commitment to providing high-quality, affordable and flexible family-forming benefits that meet the diverse needs of today's workforce.

ARC® Fertility, a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, is excited to announce the upcoming webinar, "How to Identify High-Value Family-forming Benefits” on March 27, 2024, at 12:00-1:00pm ET. In collaboration with Leapfrog, this webinar is a testament to Leapfrog's dedication to fostering industry dialogue through its Partner Advisory Committee (PAC) where ARC Fertility is a proud member.

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly marks the one-year anniversary of Bill Glueck's role as Executive Vice President of Partnerships & Platform Integrations. Glueck has played a pivotal role in advancing ARC’s mission of making affordable, flexible fertility and family-forming benefits more accessible for self-insured employers and their employees.

ARC Fertility, a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, is taking a bold step forward in addressing health equity with innovative solutions designed to make family-forming benefits accessible to all. Recognizing the diverse needs of individuals on their journey to parenthood, ARC Fertility is committed to breaking down barriers and fostering inclusivity in fertility care.

David Adamson, MD, founder and CEO, ARC® Fertility, a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, is first co-author of a leading-edge study titled, "Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature." Published in Human Reproduction Update, the findings address the critical issues surrounding declining fertility rates and their profound societal implications.

ARC Fertility, a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, responds to the fertility benefits requirements of mid-to-large size companies, plan sponsors and administrators with 5,000-10,000+ employees, offering a flexible, more cost-effective approach to reproductive care services. Brokers, third party administrators, benefits consultants and other intermediaries can now meet the expectations of the self-funded marketplace with adaptable solutions that can be tailored to individual needs.

David Adamson, MD, founder and CEO, ARC® Fertility, a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, has co-authored a new study published in the prestigious journal, Human Reproduction, whose novel findings can serve as a guide for self-insured employers to advance gender equality in improving access to assisted reproductive technology (ART).

ARC Fertility, a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, announces David Adamson, MD, founder and CEO, ARC Fertility, as a co-author in the new book Benefits Revolution: The Next Generation of Employer-Sponsored Healthcare. Dr. Adamson outlines why employers should implement family-forming benefits into employee health plans, providing actionable steps benefits advisors can take to deliver better, more cost-effective outcomes for clients and patients.

ARC Fertility, a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, raises the bar for the industry to help health plan payers experience higher quality care, better patient outcomes, lower costs and scalability that ensures care consistency nationwide.

ARC Fertility, a pioneer in innovative fertility and family-forming treatment options, will proudly be supporting the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress and Expo in New Orleans. The event begins today, October 14, and lasts through October 18. A longtime supporter of ASRM, ARC Fertility founder and CEO Dr. G. David Adamson previously served as president for the society. He’ll be joined by ARC leadership for this year’s program.

ARC Fertility, a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, underscores the importance of affordability and accessibility as companies, plan sponsors, health insurance brokers, third-party administrators and benefits consultants conduct open enrollment activities.

ARC Fertility, a pioneer in innovative fertility and family-forming treatment options and benefits for employers and employees, is proud to join the PlanSource partner marketplace and bring family-forming benefits to as many people as possible for the 2024 Open Enrollment season and beyond. The Summer Release includes ARC Fertility as a partner for the first time. PlanSource is a best-in-class benefits engagement platform investing in innovation and solving fundamental benefit needs differently to improve health outcomes of employees and their families.

ARC Fertility, a pioneer in innovative fertility treatment options, urges employers to honor Pride 2023 by ensuring all team members have equal access to family forming healthcare benefits. The LGBTQIA+ community has won many victories, but their struggle for reproductive rights is not over, and business leaders can do their part by ensuring equality and equity when it comes to benefits. Employers will only gain by offering the best fertility care for all employees regardless of gender, orientation, or background, attracting and retaining the diverse workforces that thrive in today’s market.

In the wake of a significant jump in births following the end of most COVID-19 restrictions, ARC Fertility, a pioneer in innovative fertility treatment options, today called for American employers to explore new ways to offer benefits that support growing families. On May 5, the World Health Organization (WHO) declared the end of COVID-19 as a global health emergency, almost two years after most US federal, state and local government agencies eliminated restrictions related to the pandemic. Researchers reported that US birth rates rose 6.2%, creating a surprise “mini baby boom” following the most dire stretches of the coronavirus epidemic.

ARC Fertility, a pioneer in innovative fertility treatment options, today announced the hiring of two new executive specialists for its leadership team. Diana Lazuka and Linda Larison will help ARC provide elite services to its network of partner clinics and interface with corporate clients to ensure easy access to the best fertility and family-forming treatments available.

ARC Fertility, a pioneer in increasing access to quality family-forming benefits for employers, today announced its full support for the Right to Build Families Act, introduced by Senators Tammy Duckworth (IL) and Patty Murray (WA) and Representative Susan Wild (PA-7). The Act was proposed in the wake of the Supreme Court’s Dobbs v. Jackson Women's Health decision, which erodes protections for reproductive rights.

ARC Fertility, a pioneer in innovative fertility treatment options, today announced it has been selected by the American Medical Women’s Association (AMWA) to provide its employees with state-of-the-art family-forming benefits.

ARC Fertility, a pioneer in innovative fertility treatment options, today reiterated its support for National Men’s Health Month. Created in 1992, this event encourages men to take care of their bodies by eating right, exercising, and working to prevent disease. Men’s Health Month also presents an opportunity to focus conversations about fertility around mental health issues because half of all issues related to forming families involve male partners.

ARC Fertility, a pioneer in innovative fertility treatment options, today announced it has been awarded the Validation Institute’s prestigious Savings validation for reducing instances of twins and higher multiple births through its evidence-based fertility care program. According to the report, ARC saved parents and employers nearly $23 million in just one year.

ARC Fertility, a pioneer in innovative fertility treatment options, is celebrating this year’s National Infertility Awareness Week (NIAW), which will take place April 24-30, 2022. ARC Fertility is marking this important week with a focus on the importance of fertility benefits that allow companies to attract and retain employees and reach their diversity goals.

ARC Fertility, a pioneer in innovative fertility treatment options, today urged People who are undergoing or considering fertility medical treatments to receive vaccines for COVID-19 as quickly as possible and to ignore unsubstantiated rumors about potential problems related to fertility and pregnancy. ARC’s recommendations are based on recent guidelines from the American Society for Reproductive Medicine about COVID and fertility, which state that “there are no fertility-related reasons for a vaccine exemption.”